Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOTIV-POSDEP
NCT04043052Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Sep 2020
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
Randomised, open-label trial in stroke and major depressive disorder (MDD) (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Hamilton Depression Rating Scale at 6 months. Started Sep 2020; status: completed.
02
Conditions
strokemajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04043052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04043052.